Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Revista Espanola De Patologia : Publicacion Oficial De La Sociedad Espanola De Anatomia Patologica Y De La Sociedad Espanola De Citologia|January 18, 2021
[Update of the recommendations for the determination of biomarkers in colorectal carcinoma. National Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology]Samuel Navarro, Miriam Cuatrecasas, Javier Hernández-Losa, et al.
Cancers|October 17, 2019
Tumor Expression of Cyclin-Dependent Kinase 5 (Cdk5) Is a Prognostic Biomarker and Predicts Outcome of Oxaliplatin-Treated Metastatic Colorectal Cancer PatientsVicenç Ruiz de Porras, Sara Bystrup, Sara Cabrero-de Las Heras, et al.
Clinical and Translational Medicine|December 26, 2025
Loss-of-function genetic screen unveils synergistic efficacy of PARG inhibition with combined 5-fluorouracil and irinotecan treatment in colorectal cancerCristina Queralt, Cristina Moreta-Moraleda, Marta Costa, et al.
Cancers|October 2, 2020
Complete Loss of EPCAM Immunoexpression Identifies <i>EPCAM</i> Deletion Carriers in MSH2-Negative Colorectal NeoplasiaMíriam Cuatrecasas, Iñigo Gorostiaga, Cristina Riera, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 8, 2024
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based TreatmentSara Cabrero-de Las Heras, Xavier Hernández-Yagüe, Andrea González, et al.
Cancer Research|February 11, 2026
Discovery and Evaluation of Biomarkers for Triple-Negative Breast Cancer Subtypes Uncovers Patient Stratification and Targeted Therapeutic StrategiesDaniel Ortega-Álvarez, David Tébar-García, Marta Casado-Peláez, et al.
Plos One|July 1, 2014
A colorectal cancer susceptibility new variant at 4q26 in the Spanish population identified by genome-wide association analysisLuis M Real, Agustín Ruiz, Javier Gayán, et al.
The Lancet. Oncology|August 31, 2016
Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysisSebastian Moran, Anna Martínez-Cardús, Sergi Sayols, et al.
Pageof 2